Rockefeller Center:(212) 765-7340
East Setauket:(631) 246-8080
Back to home
Preserve Your Teeth Dentistry

Steven Engebretson, DMD, MS, MS

Experience integrative and biological dentistry with a minimally invasive approach. Serving NYC & Long Island with advanced, patient-focused care designed to preserve your natural teeth.

View live source
Selected Publications

Rockefeller Center: (212) 765-7340 630 5th Avenue, Suite 1860, New York, NY 10111 East Setauket: (631) 246-8080 196 Belle Meade Road, Suite 6, East Setauket, NY 11733 Contact Request Appointment Dentist in New York City Steven Engebretson, DMD, MS, MS Steven Engebretson, DMD, MS, MS Dr.

Steven Engebretson received his Doctor of Dental Medicine cum lauda et thesis propria from Harvard School of Dental Medicine.

He also holds two Master of Science degrees, one in Periodontics from Columbia University and the other in Biostatistics, focusing on patient-oriented research from the Mailman School of Public Health at Columbia University.

His academic career has included full-time academic appointments at three colleges of dental medicine: Columbia University, Stony Brook University, and New York University.

Engebretson is an Associate Professor in the Ashman Department of Periodontology and Implant Dentistry at New York University College of Dentistry, where he has served as Department Chair and Program Director of the Advanced Education Program in Periodontics.

He is also an expert in the area of diabetes and oral health and has been invited to speak at seminars and workshops in North America, Europe, and the Middle East.

Engebretson received a $12.5 M grant from the NIH (National Institute of Health) in 2008 for a critical diabetes and periodontics clinical trial: The Diabetes and Periodontal Therapy Trial (DPTT).

Engebretson was the Study Chair and Principal Investigator of this award, which he completed in 2013.

He is also the principal investigator on three supplemental awards for the DPTT totaling more than $2.5 M.

This multi-center national clinical trial, the largest study of its kind in the United States, evaluates whether treatment of chronic periodontitis will help improve diabetes control.

He has served as thesis advisor and mentor to seven Master's Degree students and two Doctoral students, as well as numerous undergraduate dental student research projects.

Engebretson served for seven years as Associate Editor of the Journal of Periodontology and served on numerous committees for the American Academy of Periodontology.

He was awarded a U.S. patent for “Methods for Facilitating Metabolic Control” and has several additional patents pending.

He is the founder of KT Therapeutics, LLC, and OraDelivery, LLC, privately-held biotechnology companies, and is a prolific author and lecturer.

Radio, a nationally broadcast live interview and call-in radio program, answering questions to listeners about periodontal health and dental implants.

Microradiography and Microcomputed Tomography Comparative Analysis in Human Bone Cores Harvested After Maxillary Sinus Augmentation: A Pilot Study.

Schoenfeld ER, Hyman L, Simpson LL, Michalowicz B, Reddy M, Gelato M, Engebretson SP, et al.

An Evaluation of Recruitment Methods Utilized for a Clinical Trial with Periodontal and Diabetes Enrollment Criteria: The Diabetes and Periodontal Therapy Trial.

Michalowicz BS, Hyman L, Hou W, Oates TW, Jr., Reddy M, Paquette DW, Engebretson SP, et al.

Factors Associated with The Clinical Response to Nonsurgical Periodontal Therapy in People with Type 2 Diabetes Mellitus.

Hemoglobin A1c Levels Among Patients with Diabetes Receiving Nonsurgical Periodontal Treatment--Reply.

A Novel Three-Dimensional Analysis of Standardized Bone Defects by Means of Confocal Scanner and Micro-Computed Tomography.

A Complex Haptic Exercise to Predict Preclinical Operative Dentistry Performance: A Retrospective Study.

Design Features of the Diabetes and Periodontal Therapy Trial (DPTT): A Multicenter Randomized Single-Masked Clinical Trial Testing the Effect of Nonsurgical Periodontal Therapy on Glycosylated Hemoglobin (HbA1c) Levels in Subjects with Type 2 Diabetes and Chronic Periodontitis.

The Effect of Nonsurgical Periodontal Therapy on Hemoglobin A1c Levels in Persons with Type 2 Diabetes and Chronic Periodontitis: A Randomized Clinical Trial.

Evidence That Periodontal Treatment Improves Diabetes Outcomes: A Systematic Review and Meta-Analysis.

Evidence That Periodontal Treatment Improves Diabetes Outcomes: A Systematic Review and Meta-Analysis.

The Use of Haptics to Predict Preclinic Operative Dentistry Performance and Perceptual Ability.

Computer-Assisted Dental Simulation as a Predictor of Preclinical Operative Dentistry Performance.

Sub-Antimicrobial Doxycycline for Periodontitis Reduces Hemoglobin A1c in Subjects with Type 2 Diabetes: A Pilot Study.

Pharmacological Research : the official journal of the Italian Pharmacological Society. 2011 Dec;64(6):624-9.

Plasma Levels of Tumour Necrosis Factor-Alpha in Patients with Chronic Periodontitis and Type 2 Diabetes.

The Influence of Diabetes on Gingival Crevicular Fluid Beta-Glucuronidase and Interleukin-8.

Gingival Crevicular Fluid Levels of Interleukin-1beta and Glycemic Control in Patients with Chronic Periodontitis and Type 2 Diabetes.

Periodontal Infections and Pre-Term Birth: Early Findings from a Cohort of Young Minority Women in New York.

The Influence of Interleukin Gene Polymorphism on Expression of Interleukin-1beta and Tumor Necrosis Factor-Alpha in Periodontal Tissue and Gingival Crevicular Fluid.

Guided Bone Regeneration Utilizing Expanded Polytetrafluoroethylene Membranes in Combination with Submerged and Nonsubmerged Dental Implants in Beagle Dogs.